Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Daptomycin is a cyclic lipopeptide antibiotic which was initially approved by the Food and Drug Administration (FDA) for the treatment of complicated skin and skin-skin structure infections in September 2003.

Myopathy Associated with Daptomycin Use